Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy
Author(s) -
Yun Chang,
Ramizah Syahirah,
Xuepeng Wang,
Gyuhyung Jin,
Sandra TorregrosaAllen,
Bennett D. Elzey,
Sydney N. Hummel,
Tianqi Wang,
Can Li,
Xiaojun Lian,
Qing Deng,
Hal E. Broxmeyer,
Xiaoping Bao
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.111128
Subject(s) - chimeric antigen receptor , induced pluripotent stem cell , cancer immunotherapy , immunotherapy , antigen , cancer research , stem cell , receptor , biology , immunology , microbiology and biotechnology , immune system , embryonic stem cell , gene , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom